Pages that link to "Q35802550"

The following pages link to Recent advances in the development of next generation non-nucleoside reverse transcriptase inhibitors (Q35802550):

Displaying 9 items.

• Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections. (Q30359545) (← links)
• Discovery of novel non-cyclam polynitrogenated CXCR4 coreceptor inhibitors (Q33356674) (← links)
• The development and validation of an UHPLC-MS/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma (Q33923694) (← links)
• Physicochemical property-driven optimization of diarylaniline compounds as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. (Q34062476) (← links)
• Design, Synthesis, and Biological Evaluation of 1-[(2-Benzyloxyl/alkoxyl)methyl]-5-halo-6-aryluracils as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile (Q35851936) (← links)
• The HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes (Q35859896) (← links)
• Concentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days. (Q36482710) (← links)
• Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives. (Q38823843) (← links)
• Access to Chiral Hydropyrimidines through Palladium-Catalyzed Asymmetric Allylic C-H Amination (Q47417152) (← links)